GHRP-6 + CJC-1295 (no DAC)
A research pairing combining the original ghrelin-receptor-agonist GH secretagogue with a GHRH analog to stimulate growth hormone release through two complementary receptor pathways.
Rationale
Complementary GH-stimulating mechanisms (GHS-R agonist + GHRH analog). Popular pairing anecdotally; not supported by controlled human outcome trials.
GHRP-6
Ghrelin-receptor (GHS-R1a) agonist that also stimulates appetite; the original growth hormone-releasing hexapeptide.
Commonly cited non-clinical use range — NOT validated
- Dose
- 100–300 mcg
- Frequency
- 1-3x daily (anecdotal)
CJC-1295 (no DAC)
GHRH analog that extends the amplitude/duration of GH pulses; commonly paired with a GHRP for a synergistic release pattern.
Commonly cited non-clinical use range (no-DAC) — NOT validated
- Dose
- 100–200 mcg
- Frequency
- 1-3x daily (anecdotal)
For research and educational purposes only. This is not medical advice. Neither peptide is FDA-approved. Consult a licensed healthcare provider before using any peptide.